Petros Pharmaceuticals

Entity > Corporation > US > New York City New York > Petros Pharmaceuticals

About Petros Pharmaceuticals

Petros Pharmaceuticals, Inc. is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring and commercializing innovative therapeutics for men's health issues, including erectile dysfunction, Peyronie's disease, hormone health and substance use disorders.

Petros Pharmaceuticals, Inc. Launches Two Self-Selection Studies For Erectile Dysfunction Drug Stendra® (Avanafil): Results from these studies will be part of a broader data package the company plans to submit to the U.S. Food and Drug Administration (FDA) to potentially obtain over-the-counterdrug status for STENDRA® (avanafil).

Petros Pharmaceuticals Is Expanding Its Program For A Novel, Non-Invasive Treatment For Peyronie's Disease: In an effort to expand its portfolio to other underserved segments, Petros Pharmaceuticals recently entered into a definitive global exclusive license agreement for a novel and patented topical formulation candidate for the treatment of Peyronie's disease (PD), which is currently in early clinical testing. If approved, this would be the first and only clinically proven topical, non-invasive treatment for acute PD, a breakthrough achievement in men's health.

Petros Pharmaceuticals' Foundation: Petros Pharmaceuticals, formerly known as Metuchen Pharma, was founded in 2020 and is headquartered in the United States.

Petros Pharmaceuticals' Vision: Petros Pharmaceuticals' vision is to provide optimised men's health solutions that address the full spectrum of conditions that are specific to men, whether they focus on the male anatomy or pose an increased risk to men.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Petros Pharmaceuticals

Company Attribute Value
Address StreetAddress: 1185 Avenue of the Americas Fl 3, AddressLocality: New York City, AddressRegion: New York, PostalCode: 10036, AddressCountry: United States
Founding Date 2020
Name Petros Pharmaceuticals
Number Of Employees 24
Revenue $6,201,000 USD
Ticker Symbol NASDAQ: PTPI
Url petrospharma
Google google

Petros Pharmaceuticals

us

New York City, US
24 Mar 2024

New York City, US
24 Mar 2024

Petros Pharmaceuticals

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://www.petrospharma.com/
Petros
We ultimately seek to establish new foundations to Men's Health that can support vital functions of a man's life. Our focus. At Petros, we seek to understand ...
https://finance.yahoo.com › quote › PTPI
Petros Pharmaceuticals, Inc. (PTPI) Stock Price, News, ...
Jan 12, 2024 — Find the latest Petros Pharmaceuticals, Inc. (PTPI) stock quote, history, news and other vital information to help you with your stock ...
https://irdirect.net › PTPI › corporate_overview
Corporate Overview | Petros
Petros is a Men's Health pharmaceutical company that aims to develop complementary therapeutics designed for a man's journey, often, we believe, centered ...
https://www.linkedin.com/company/petros-pharmaceuticals
Petros Pharmaceuticals
We seek to understand the various health phases throughout a man's journey. We collaborate with researchers, scientists, medical thought leaders ...
https://finance.yahoo.com › news › petros-pharmaceuti...
Petros Pharmaceuticals Announces Two Upcoming FDA ...
Jan 24, 2024 — The Company has scheduled a Type C meeting with the FDA on March 26, 2024, to review the Company's developing digital app for use under the ...
https://www.marketwatch.com › ... › United States
Petros Pharmaceuticals Inc. Stock Quote (U.S. - PTPI
Petros Pharmaceuticals, Inc. engages in men's health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, ...
https://www.cnbc.com › quotes › PTPI
PTPI: Petros Pharmaceuticals Inc - Stock Price, Quote and ...
Petros Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on men's health therapeutics with a full range of commercial capabilities ...
https://www.bloomberg.com › quote › PTPI:US
PTPI: Petros Pharmaceuticals Inc Stock Price Quote
Petros Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company focuses on therapeutics that promotes medication adherence, tolerability, and ...
Related Searches
Related Searches
Petros pharmaceuticals products
Petros pharmaceuticals fda approval
Petros pharmaceuticals stock
Knowledge Panel
Knowledge Panel

Petros Pharma (Pharmaceutical company)

petrospharma.com/

We seek to understand the various health phases throughout a man's journey. We collaborate with researchers, scientists, medical thought leaders and payers to ensure our therapies aid in restoring men's body function to vitality. Website https://www.petrospharma.com/ External link for Petros Pharmaceuticals.

linkedin.com/company/petros-pharmaceuticals#:~:text=We%20seek%20to%20understand%20the,External%20link%20for%20Petros%20Pharmaceuticals
  • Stock price : PTPI (NASDAQ) $1.50 0.00 (0.00%)Mar 22, 4:00 PM EDT - Disclaimer
  • Headquarters : United States
  • Founded : 2020

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 193781